HMGA1 Has Predictive Value in Response to Chemotherapy in Gastric Cancer

Gastric cancer is a serious health problem worldwide. Although its incidence is decreasing, the five-year survival rate remains low. Thus, it is essential to identify new biomarkers that could promote better diagnosis and treatment of patients with gastric cancer. High-mobility group AT-hook 1 (HMGA...

Descripción completa

Detalles Bibliográficos
Autores principales: Pádua, Diana, Pinto, Débora Filipa, Figueira, Paula, Pereira, Carlos Filipe, Almeida, Raquel, Mesquita, Patrícia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774981/
https://www.ncbi.nlm.nih.gov/pubmed/35049679
http://dx.doi.org/10.3390/curroncol29010005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774981/
https://www.ncbi.nlm.nih.gov/pubmed/35049679
http://dx.doi.org/10.3390/curroncol29010005

Ejemplares similares